Navigation Links
Anesiva to Announce Third Quarter 2007 Financial Results and Host Webcast Conference Call on November 1, 2007
Date:10/24/2007

SOUTH SAN FRANCISCO, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) will announce financial results for the third quarter 2007 after the markets close on Thursday, November 1, 2007 and will hold a webcast teleconference at 4:30 p.m. EDT that day. Members of Anesiva's management team will discuss financial results from the third quarter 2007 as well as provide an overview of the company's product pipeline, recent events and milestones.

Interested parties can listen to the live audio webcast by dialing 877-886-3540 (international dial: 706-643-9304) or by logging on to http://www.anesiva.com and going to the Investor Information page. For those unable to participate via the Internet, a 24-hour replay will be available for seven days after the call by dialing 800-642-1687 (international dial: 706-645-9291) and giving the following pass code: 21417682. The webcast will be available until the company's next quarterly financial results conference call.

About Anesiva and its Diverse Pipeline of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has one FDA-approved product, Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, to reduce pain associated with peripheral venous access procedures in children three to 18 years of age. The second product in Anesiva's pipeline, Adlea(TM) (formerly 4975), has been shown to reduce pain after only a single administration for weeks to months in multiple settings in numerous mid-stage clinical trials for site-specific, modera
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. OHSU Researchers Announce New Discovery
2. PM announces a new health care order for India
3. Partnership Between Diabetes India And Elsevier Announced
4. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ectually disabled Australians will soon enjoy bett...new Medicare rebate created// at the AMA’s urging,...group, people with an intellectual disability have...any Australians, mostly because they can find it d...
... with mesothelioma — a form of cancer associated w...e when treated with a combination// of two cancer ...ma, a rare but aggressive form of cancer that occu...gs, heart and abdomen, is associated with exposure...
... A botched up family planning operation would have...ing British doctor of Indian origin// wasn't there...ctor Ashok Vardhan's visit to Purnea district, 300...ti Devi, who was comatose after a portion of her l...
...ientists have come out strongly against the NHS's ...r to those in the age group 25 to 29, leaving// o...e doctors, Consultant cytopathologists Amanda Herb...dation Trust in London, and John Smith, from the R...
Other Medicine News:Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 3Health News:Extend Cervical Smears to Younger Women, Insist Specialists 2
(Date:9/3/2008)...m chronically infected Hepatitis C,patients strong...er in 2008, - Study is the first to show a stati...l effect of therapeutic Hepatitis C vaccination, ...o a second generation, vaccine formulated with In... activation, VIENNA, Aus...
(Date:9/3/2008)... (dronedarone) decreased the risk of,stroke by 34%...tter already adequately treated by an.../- The results of a,post-ho...presented today at,the clinical trial update sessi...2008, in Munich, Germany. Previous results from th...
(Date:9/3/2008)...-Dosing Study in Subjects with ALS, RICHMOND, Cal...Sciences, Inc. (Nasdaq: SGMO ) announced today th...801) to evaluate its drug, SB-509, in subjects,wit...sease for which there,are limited treatment option...ectable formulation of a plasmid,encoding a zinc f...
(Date:9/2/2008)...ONE to Build Hope and Give Help, MINNEAPOLIS, Sep...epublican Party Convention are sending a message t... including evacuees in the Gulf Coast region,and t...ntries: "We are here,to help.", World Vision and ...o,something unconventional. This event provides an...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4The Valley Hospital in Ridgewood NJ Announces Historic 2430 Million Gift 21926 1The Valley Hospital in Ridgewood NJ Announces Historic 2430 Million Gift 21926 2Harvard Study in Joint Commission Journal 3A Mortality Rates Lower in Leapfrog Hospitals 21922 1Harvard Study in Joint Commission Journal 3A Mortality Rates Lower in Leapfrog Hospitals 21922 2Harvard Study in Joint Commission Journal 3A Mortality Rates Lower in Leapfrog Hospitals 21922 3Celator 28R 29 Pharmaceuticals to Present at 2008 BIO International Convention 6007 1Test of bacteria toxin delivery system could pave way for new antibiotic drugs 3646 1Test of bacteria toxin delivery system could pave way for new antibiotic drugs 3646 2
...r , Some form of electronic hematology analy...tories. A blood cell count is usually the first sc...ut anemia or infection, and monitor cancer patient...lt to imagine medical care without this workhorse ... Early testing of sonar, developed to detect subma...
...ting Editor , ,Positive patient identificatio...dies for the past few years. Until recently, the ...eyond the reach of the average hospital or laborat...s that can be integrated into a facilitys IS requi...all facilities, while others are best for larger i...
Other Medicine Technology:Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 2Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 3Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4
...ment introduction. The design of the introducer fe...ition profile between the introducer sheath and in...h fascial tissue and strictured areas. Proximal re...ducer sheath and introducer dilator during sheath ...
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: